Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher-Risk Myelodysplastic Syndromes

Clinical trial NCT04951778 · TERMINATED

Trial details

NCT number: NCT04951778
Sponsor: Celgene
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Myelodysplastic Syndromes

Start date: 2021-12-02
Primary completion: 2025-07-30
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.